Literature DB >> 23584990

rna interference targeting p110β reduces tumor necrosis factor-alpha production in cellular response to wear particles in vitro and osteolysis in vivo.

Jian-bin Huang1, Yue Ding, Dong-sheng Huang, Wei-ke Zeng, Zhi-ping Guan, Mao-lin Zhang.   

Abstract

Aseptic joint loosening is a key factor that reduces the life span of arthroplasty. There are currently few effective treatments for joint loosening except surgical revision. We explored the inhibitory effects of p110β-targeted small interfering RNA (siRNA) and lentivirus on particle-induced inflammatory cytokine expression in the murine macrophage cell line, RAW264.7. siRNA- and lentivirus-targeting p110β were transfected and infected prior to particle stimulation, respectively. Ceramic and titanium particles of different sizes were prepared to stimulate macrophages. Fluorescence microscopy showed that the efficiency of siRNA transfection and lentivirus infection were 74.2 ± 4.2 and 92.3 ± 2.6 %, respectively. TNF-alpha mRNA in the particle stimulation plus RNA interference (RNAi) groups were significantly lower compared with the particle stimulation-only groups (P < 0.05). Similarly, protein levels of TNF-alpha in RNAi-treated groups were significantly decreased after transfection or infection (P < 0.05). It showed that Phosphor-AKT (Ser473) activation was significantly reduced by RNAi through western blot. As assessed by CT, micro-CT and histological analysis, particle implantation induced a significant osteolysis in mice calvaria, which was limited by p110β lentivirus addition. These results suggested that p110β subtype of PI3K, followed by activation of Ser473, may possibly participate in the regulation of macrophages activity by wear particles, ultimately resulting in the TNF-α secretion and osteolysis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23584990     DOI: 10.1007/s10753-013-9636-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  30 in total

Review 1.  The role of osteoclast differentiation in aseptic loosening.

Authors:  Edward M Greenfield; Yamming Bi; Ashraf A Ragab; Victor M Goldberg; R Renee Van De Motter
Journal:  J Orthop Res       Date:  2002-01       Impact factor: 3.494

Review 2.  Latest development in viral vectors for gene therapy.

Authors:  Kenneth Lundstrom
Journal:  Trends Biotechnol       Date:  2003-03       Impact factor: 19.536

3.  Exploring the specificity of the PI3K family inhibitor LY294002.

Authors:  Severine I Gharbi; Marketa J Zvelebil; Stephen J Shuttleworth; Tim Hancox; Nahid Saghir; John F Timms; Michael D Waterfield
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

4.  Differential effects of biologic versus bisphosphonate inhibition of wear debris-induced osteolysis assessed by longitudinal micro-CT.

Authors:  Ryosuke Tsutsumi; Colleen Hock; C Dustin Bechtold; Steven T Proulx; Susan V Bukata; Hiromu Ito; Hani A Awad; Takashi Nakamura; Regis J O'Keefe; Edward M Schwarz
Journal:  J Orthop Res       Date:  2008-10       Impact factor: 3.494

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

6.  Particles of all sizes provoke inflammatory responses in vivo.

Authors:  S P Zysk; H H Gebhard; T Kalteis; M Schmitt-Sody; V Jansson; K Messmer; A Veihelmann
Journal:  Clin Orthop Relat Res       Date:  2005-04       Impact factor: 4.176

7.  A comparison of quality of life before and after arthroplasty in patients who had arthrosis of the hip joint.

Authors:  I Wiklund; B Romanus
Journal:  J Bone Joint Surg Am       Date:  1991-06       Impact factor: 5.284

8.  Inhibition of the PI3K-Akt signaling pathway reduces tumor necrosis factor-alpha production in response to titanium particles in vitro.

Authors:  Matthew V Smith; Michael J Lee; Andrew S Islam; Jacqueline L Rohrer; Victor M Goldberg; Michelle A Beidelschies; Edward M Greenfield
Journal:  J Bone Joint Surg Am       Date:  2007-05       Impact factor: 5.284

Review 9.  Role of phosphoinositide 3-kinase in innate immunity.

Authors:  Kaoru Hazeki; Kiyomi Nigorikawa; Osamu Hazeki
Journal:  Biol Pharm Bull       Date:  2007-09       Impact factor: 2.233

Review 10.  RNA interference in cancer.

Authors:  Andrei L Gartel; Eugene S Kandel
Journal:  Biomol Eng       Date:  2006-02-08
View more
  6 in total

Review 1.  PI3Kβ-A Versatile Transducer for GPCR, RTK, and Small GTPase Signaling.

Authors:  Anne R Bresnick; Jonathan M Backer
Journal:  Endocrinology       Date:  2019-03-01       Impact factor: 4.736

2.  The USP14-NLRC5 pathway inhibits titanium particle-induced osteolysis in mice by suppressing NF-κB and PI3K/AKT activities.

Authors:  Guibin Fang; Yuan Fu; Shixun Li; Junxiong Qiu; Manyuan Kuang; Sipeng Lin; Changchuan Li; Yue Ding
Journal:  J Biol Chem       Date:  2020-04-09       Impact factor: 5.157

Review 3.  Gene Expression in Osteolysis: Review on the Identification of Altered Molecular Pathways in Preclinical and Clinical Studies.

Authors:  Francesca Veronesi; Matilde Tschon; Milena Fini
Journal:  Int J Mol Sci       Date:  2017-02-25       Impact factor: 5.923

4.  MiR-92a/KLF4/p110δ regulates titanium particles-induced macrophages inflammation and osteolysis.

Authors:  Zhenkang Wen; Sipeng Lin; Changchuan Li; Zhuji Ouyang; Zhong Chen; Shixun Li; Yuxi Huang; Wenqiang Luo; Zhongcan Zheng; Peidong Guo; Manyuan Kuang; Yue Ding
Journal:  Cell Death Discov       Date:  2022-04-13

5.  Wear particles enhance autophagy through up-regulation of CD147 to promote osteoclastogenesis.

Authors:  Baohua Su; Deng Li; Jie Xu; Yingbin Zhang; Zhiqing Cai; Max Daniel Kauther; Ruofan Ma
Journal:  Iran J Basic Med Sci       Date:  2018-08       Impact factor: 2.699

6.  Titanium particle‑mediated osteoclastogenesis may be attenuated via bidirectional ephrin‑B2/eph‑B4 signaling in vitro.

Authors:  Yu-Wei Ge; Zhi-Qing Liu; Zhen-Yu Sun; De-Gang Yu; Kai Feng; Zhen-An Zhu; Yuan-Qing Mao
Journal:  Int J Mol Med       Date:  2018-07-17       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.